DK1071418T3 - Nye behandlinger til nervelidelser - Google Patents

Nye behandlinger til nervelidelser

Info

Publication number: DK1071418T3
Authority: DK; Denmark
Prior art keywords: new treatments; nerve disorders; reboxetine; noradrenaline reuptake; new
Prior art date: 1998-04-13

Application number

DK99918423T

Other languages

English (en)

Inventor

John Michael Mccall

Duncan Paul Taylor

Voigtlander Philip F Von

Erik Ho Fong Wong

Adriana Dubini

Original Assignee

Pharmacia Italia Spa

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-13

Filing date

1999-04-02

Publication date

2005-01-03

1999-04-02 Application filed by Pharmacia Italia Spa, Upjohn Co filed Critical Pharmacia Italia Spa

2005-01-03 Application granted granted Critical

2005-01-03 Publication of DK1071418T3 publication Critical patent/DK1071418T3/da

Links

210000005036 nerve Anatomy 0.000 title 1
238000011282 treatment Methods 0.000 title 1
208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 2
CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical compound CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 abstract 2
229960003770 reboxetine Drugs 0.000 abstract 2
230000001430 anti-depressive effect Effects 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
239000002858 neurotransmitter agent Substances 0.000 abstract 1
239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 1
229940126569 noradrenaline reuptake inhibitor Drugs 0.000 abstract 1
230000000966 norepinephrine reuptake Effects 0.000 abstract 1
208000019906 panic disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Mobile Radio Communication Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

DK99918423T 1998-04-13 1999-04-02 Nye behandlinger til nervelidelser DK1071418T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US8163298P	1998-04-13	1998-04-13
IT98MI000870 IT1305322B1 (it)	1998-04-23	1998-04-23	Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P	1998-05-11	1998-05-11
EP99918423A EP1071418B1 (en)	1998-04-13	1999-04-02	New treatments for nervous disorders

Publications (1)

Publication Number	Publication Date
DK1071418T3 true DK1071418T3 (da)	2005-01-03

Family

ID=11379879

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99918423T DK1071418T3 (da)	1998-04-13	1999-04-02	Nye behandlinger til nervelidelser

Country Status (25)

Country	Link
US (1)	US6391876B1 (da)
EP (1)	EP1071418B1 (da)
JP (1)	JP2002511408A (da)
KR (1)	KR100555279B1 (da)
CN (1)	CN1197569C (da)
AT (1)	ATE277617T1 (da)
AU (1)	AU755612B2 (da)
BR (1)	BR9909476A (da)
CA (1)	CA2320722A1 (da)
DE (1)	DE69920679T2 (da)
DK (1)	DK1071418T3 (da)
EA (1)	EA003546B1 (da)
ES (1)	ES2228035T3 (da)
HU (1)	HUP0101748A3 (da)
IL (1)	IL138887A0 (da)
IT (1)	IT1305322B1 (da)
NO (1)	NO20005131L (da)
NZ (1)	NZ507693A (da)
PL (1)	PL194039B1 (da)
PT (1)	PT1071418E (da)
SI (1)	SI1071418T1 (da)
SK (1)	SK14482000A3 (da)
TR (1)	TR200002970T2 (da)
WO (1)	WO1999052518A2 (da)
ZA (1)	ZA200004480B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6500827B2 (en) *	1998-05-08	2002-12-31	Pharmacia & Upjohn Company	Drug combinations
DE60022692T2 (de)	1999-07-01	2006-06-22	Pharmacia & Upjohn Co. Llc, Kalamazoo	(S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
EP1632235A3 (en) *	1999-07-01	2006-06-14	Pharmacia & Upjohn Company LLC	Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
PL366119A1 (en) *	2000-11-15	2005-01-24	Eli Lilly And Company	Treatment of anxiety disorders
US20070010517A1 (en) *	2002-06-17	2007-01-11	Annalisa Airoldi	Pharmaceutical salts of reboxetine
US20100069389A1 (en) *	2008-09-06	2010-03-18	Bionevia Pharmaceuticals, Inc.	Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL56369A (en)	1978-01-20	1984-05-31	Erba Farmitalia	Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en)	1984-08-02	1984-09-05	Erba Farmitalia	3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en)	1984-11-22	1988-05-11	Erba Farmitalia	Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
ZA989251B (en)	1997-10-17	2000-04-10	Lilly Co Eli	Potentiation of pharmaceuticals.

1998
- 1998-04-23 IT IT98MI000870 patent/IT1305322B1/it active
1999
- 1999-04-02 BR BR9909476-2A patent/BR9909476A/pt not_active Application Discontinuation
- 1999-04-02 EP EP99918423A patent/EP1071418B1/en not_active Expired - Lifetime
- 1999-04-02 TR TR2000/02970T patent/TR200002970T2/xx unknown
- 1999-04-02 US US09/673,768 patent/US6391876B1/en not_active Expired - Fee Related
- 1999-04-02 PL PL99346294A patent/PL194039B1/pl unknown
- 1999-04-02 AU AU36351/99A patent/AU755612B2/en not_active Ceased
- 1999-04-02 WO PCT/US1999/004288 patent/WO1999052518A2/en not_active Ceased
- 1999-04-02 KR KR1020007011336A patent/KR100555279B1/ko not_active Expired - Fee Related
- 1999-04-02 ES ES99918423T patent/ES2228035T3/es not_active Expired - Lifetime
- 1999-04-02 PT PT99918423T patent/PT1071418E/pt unknown
- 1999-04-02 HU HU0101748A patent/HUP0101748A3/hu active IP Right Revival
- 1999-04-02 AT AT99918423T patent/ATE277617T1/de not_active IP Right Cessation
- 1999-04-02 CA CA002320722A patent/CA2320722A1/en not_active Abandoned
- 1999-04-02 DK DK99918423T patent/DK1071418T3/da active
- 1999-04-02 DE DE69920679T patent/DE69920679T2/de not_active Expired - Fee Related
- 1999-04-02 IL IL13888799A patent/IL138887A0/xx not_active IP Right Cessation
- 1999-04-02 JP JP2000543128A patent/JP2002511408A/ja active Pending
- 1999-04-02 CN CNB99804010XA patent/CN1197569C/zh not_active Expired - Fee Related
- 1999-04-02 EA EA200001058A patent/EA003546B1/ru not_active IP Right Cessation
- 1999-04-02 SI SI9930684T patent/SI1071418T1/xx unknown
- 1999-04-02 SK SK1448-2000A patent/SK14482000A3/sk unknown
- 1999-04-02 NZ NZ507693A patent/NZ507693A/en unknown
2000
- 2000-08-29 ZA ZA200004480A patent/ZA200004480B/en unknown
- 2000-10-12 NO NO20005131A patent/NO20005131L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU755612B2 (en)	2002-12-19
JP2002511408A (ja)	2002-04-16
DE69920679T2 (de)	2006-03-02
PL194039B1 (pl)	2007-04-30
EA003546B1 (ru)	2003-06-26
EP1071418B1 (en)	2004-09-29
SK14482000A3 (sk)	2001-08-06
ATE277617T1 (de)	2004-10-15
CA2320722A1 (en)	1999-10-21
EP1071418A2 (en)	2001-01-31
ES2228035T3 (es)	2005-04-01
CN1293569A (zh)	2001-05-02
HUP0101748A3 (en)	2001-12-28
PT1071418E (pt)	2004-12-31
ITMI980870A1 (it)	1999-10-23
NO20005131D0 (no)	2000-10-12
NO20005131L (no)	2000-10-12
KR20010042641A (ko)	2001-05-25
ZA200004480B (en)	2002-04-24
CN1197569C (zh)	2005-04-20
NZ507693A (en)	2003-08-29
BR9909476A (pt)	2000-12-19
IL138887A0 (en)	2001-11-25
DE69920679D1 (de)	2004-11-04
KR100555279B1 (ko)	2006-03-03
PL346294A1 (en)	2002-01-28
WO1999052518A3 (en)	1999-12-02
US6391876B1 (en)	2002-05-21
SI1071418T1 (en)	2005-04-30
HUP0101748A2 (hu)	2001-11-28
IT1305322B1 (it)	2001-05-04
TR200002970T2 (tr)	2001-01-22
WO1999052518A2 (en)	1999-10-21
AU3635199A (en)	1999-11-01
EA200001058A1 (ru)	2001-04-23

Publication	Publication Date	Title
DK1071418T3 (da)	2005-01-03	Nye behandlinger til nervelidelser
PT971713E (pt)	2003-09-30	Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
DE602004015257D1 (de)	2008-09-04	Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels
TR200000755T2 (tr)	2000-09-21	Karşıt olma-karşı gelme bozukluğunun tedavisi.
MY134110A (en)	2007-11-30	Combinations of reboxetine and neuroleptic agents
ATE329588T1 (de)	2006-07-15	Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
WO2003026478A3 (en)	2003-09-18	System and method for diagnosing and/or reducing tinnitus
NO20021035L (no)	2002-05-02	Fremgangsmåter for anvendelse av rasktvirkende selective serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
DE602004031893D1 (de)	2011-04-28	Verwendung des Enantiomers (1S, 2R) von Milnacipran zur Herstellung eines Arzneimittels
AR058239A1 (es)	2008-01-23	Metodos para tratar trastornos de ansiedad
WO2002077198A8 (en)	2003-08-21	Methods of modulating angiogenesis
TR200200014T2 (tr)	2002-05-21	Nörotik düzensizliklerin tedavisi.
MY136367A (en)	2008-09-30	Treatment of cognitive failure
WO2002040006A3 (en)	2003-12-24	Treatment of anxiety disorders
NO20005621L (no)	2000-11-07	Nye medikamentkombinasjoner
DE69912743D1 (de)	2003-12-18	Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
CO4950552A1 (es)	2000-09-01	Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b
DK1152757T3 (da)	2005-10-31	MMP-inhibitorer i bindevævsblödhed
PT1054671E (pt)	2003-03-31	Nova utilizacao da ropivacaina para o controlo da dor
DK1455770T3 (da)	2007-10-08	Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
ECSP034647A (es)	2003-07-25	Uso de factor vii actividad de coagulacion para tratar sangrados graves inducidos por terapia
ATE406880T1 (de)	2008-09-15	Behandlung von motorischen veränderungen mit 5- hydrxoytryptamin 1a rezeptor aktivität verstärkenden wirkstoffen
PT1282414E (pt)	2005-04-29	Compostos derivados de felbamato para o tratamento da dor neuropatica
ZA991638B (en)	1999-09-01	Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism.
FR2816633B1 (fr)	2003-02-07	Methode de criblage d'agents susceptibles de traiter l'obesite